Peter Rossing

Peter Rossing

Clinical Professor

Member of:

  • Internal Medicine: Endocrinology

ORCID: 0000-0002-1531-4294

Publication year:
All
151 - 200 out of 508Page size: 50
  1. 2022
  2. Published

    Kidney oxygenation, perfusion and blood flow in people with and without type 1 diabetes

    Laursen, J. C., Søndergaard-Heinrich, N., Haddock, B., Rasmussen, I. K. B., Hansen, C. S., Larsson, Henrik Bo Wiberg, Groop, P., Bjornstad, P., Frimodt-Møller, M., Andersen, U. B. & Rossing, Peter, 2022, In: Clinical Kidney Journal. 15, 11, p. 2072-2080 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Liraglutide Lowers Palmitoleate Levels in Type 2 Diabetes: A Post Hoc Analysis of the LIRAFLAME Randomized Placebo-Controlled Trial

    Wretlind, A., Zobel, E. H., De Zawadzki, A., Ripa, Rasmus Sejersten, Curovic, V. R., Von Scholten, B. J., Mattila, I. M., Hansen, T. W., Kjær, Andreas, Vestergaard, H., Rossing, Peter & Legido-Quigley, C., 2022, In: Frontiers in Clinical Diabetes and Healthcare. 3, 8 p., 856485.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Making an impact on kidney disease in people with type 2 diabetes: the importance of screening for albuminuria

    McGill, J. B., Haller, H., Roy-Chaudhury, P., Cherrington, A., Wada, T., Wanner, C., Ji, L. & Rossing, Peter, 2022, In: BMJ open diabetes research & care. 10, 4

    Research output: Contribution to journal › Review › Research › peer-review

  5. Published

    Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

    Davies, M. J., Aroda, V. R., Collins, B. S., Gabbay, R. A., Green, J., Maruthur, N. M., Rosas, S. E., Del Prato, S., Mathieu, C., Mingrone, G., Rossing, Peter, Tankova, T., Tsapas, A. & Buse, J. B., 2022, In: Diabetes Care. 45, 11, p. 2753-2786 34 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

    Davies, M. J., Aroda, V. R., Collins, B. S., Gabbay, R. A., Green, J., Maruthur, N. M., Rosas, S. E., Del Prato, S., Mathieu, C., Mingrone, G., Rossing, Peter, Tankova, T., Tsapas, A. & Buse, J. B., 2022, In: Diabetologia. 65, 12, p. 1925-1966 42 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Microalbuminuria Constitutes a Clinical Action Item for Clinicians in 2021

    Rossing, Peter & Epstein, M., 2022, In: American Journal of Medicine. 135, 5, p. 576-580 5 p.

    Research output: Contribution to journal › Review › Research › peer-review

  8. Published

    Multiomics signatures of type 1 diabetes with and without albuminuria

    Clos-Garcia, M., Ahluwalia, Tarun Veer Singh, Winther, S. A., Henriksen, P., Ali, M., Fan, Yong, Stankevic, Evelina, Lyu, Liwei, Vogt, J. K., Hansen, Torben, Legido-Quigley, C., Rossing, Peter & Pedersen, Oluf Borbye, 2022, In: Frontiers in Endocrinology. 13, 17 p., 1015557.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Non-dipping and higher nocturnal blood pressure are associated with risk of mortality and development of kidney disease in type 1 diabetes

    Hjortkjær, H., Persson, F., Theilade, S., Winther, S. A., Tofte, N., Ahluwalia, Tarun Veer Singh & Rossing, Peter, 2022, In: Journal of Diabetes and its Complications. 36, 9, 6 p., 108270.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Novel topical allogeneic bone-marrow-derived mesenchymal stem cell treatment of hard-to-heal diabetic foot ulcers: a proof of concept study

    Andersen, Jonas Askø, Rasmussen, A., Frimodt-Møller, M., Engberg, S., Steeneveld, E., Kirketerp-Møller, K., O’Brien, T. & Rossing, Peter, 2022, In: Stem Cell Research and Therapy. 13, 1, 280.

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    Organic Anion Transporter Gene Variants Associated With Plasma Exposure and Long-Term Response to Atrasentan in Patients With Diabetic Kidney Disease

    Smeijer, J. D., Koomen, J. V., Kohan, D. E., McMurray, J. J. V., Bakris, G. L., Correa-Rotter, R., Hou, F. F., Kitzman, D. W., Makino, H., Mayer, G., Nowicki, M., Perkovic, V., Rossing, Peter, Tobe, S., Parving, H. H., de Zeeuw, D. & Heerspink, H. J. L., 2022, In: Clinical Pharmacology and Therapeutics. 112, 5, p. 1098-1107

    Research output: Contribution to journal › Journal article › Research › peer-review

  12. Published

    Precision diagnostic approach to predict 5-year risk for microvascular complications in type 1 diabetes

    Al-Sari, N., Kutuzova, Svetlana, Suvitaival, T., Henriksen, P., Pociot, Flemming, Rossing, Peter, McCloskey, D. & Legido-Quigley, C., 2022, In: EBioMedicine. 80, 104032.

    Research output: Contribution to journal › Journal article › Research › peer-review

  13. Published

    Quételet (body mass) index and effects of dapagliflozin in chronic kidney disease

    Chertow, G. M., Vart, P., Jongs, N., Langkilde, A. M., McMurray, J. J. V., Correa-Rotter, R., Rossing, Peter, Sjöström, C. D., Stefansson, B. V., Toto, R. D., Wheeler, D. C. & Heerspink, H. J. L., 2022, In: Diabetes, Obesity and Metabolism. 24, 5, p. 827-837 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  14. Published

    Randomized Controlled Trial of the Hemodynamic Effects of Empagliflozin in Patients With Type 2 Diabetes at High Cardiovascular Risk: The SIMPLE Trial

    Wolsk, E., Jürgens, M., Schou, Morten, Ersbøll, M., Hasbak, P., Kjær, Andreas, Zerahn, B., Brandt, N. H., Gæde, P. H., Rossing, Peter, Faber, Jens, Inzucchi, S. E., Kistorp, Caroline Michaela Nervil & Gustafsson, Finn, 2022, In: Diabetes. 71, 4, p. 812-820 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  15. Published

    Real life evaluation of sodium-glucose cotransporter 2 inhibition in type 1 diabetes and the risk of diabetic ketoacidosis

    Stougaard, E. B., Kristensen, Peter Lommer, Kielgast, U., Andersen, H. U., Hamid, Y., Gæde, P. H., Søndergaard, E., Dørflinger, G. H., Fjeldborg, K. K., Hansen, K. W., Thomsen, H. H., Al-Imar, T. M. J., Røder, M., Sridhar, V. S., Cherney, D., Rossing, Peter & Persson, F., 2022, In: Diabetes & vascular disease research. 19, 5, p. 14791641221130043

    Research output: Contribution to journal › Journal article › Research › peer-review

  16. Published

    Report from the CVOT Summit 2021: new cardiovascular, renal, and glycemic outcomes

    Schnell, O., Battelino, T., Bergenstal, R., Blüher, M., Böhm, M., Brosius, F., Carr, R. D., Ceriello, A., Forst, T., Giorgino, F., Guerci, B., Heerspink, H. J. L., Itzhak, B., Ji, L., Kosiborod, M., Lalić, N., Lehrke, M., Marx, N., Nauck, M., Rodbard, H. W. & 10 others, Rosano, G. M. C., Rossing, Peter, Rydén, L., Santilli, F., Schumm-Draeger, P., Vandvik, P. O., Vilsbøll, Tina, Wanner, C., Wysham, C. & Standl, E., 2022, In: Cardiovascular Diabetology. 21, 1, 50.

    Research output: Contribution to journal › Journal article › Research › peer-review

  17. Published

    Safety and efficacy of dapagliflozin in patients with focal segmental glomerulosclerosis: a prespecified analysis of the dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial

    Wheeler, D. C., Jongs, N., Stefansson, B., Chertow, G. M., Greene, T., Hou, F. F., Langkilde, A. M., McMurray, J. J., Rossing, Peter, Nowicki, M., Wittmann, I., Correa-Rotter, R., Sjostrom, C. D., Toto, R. D., Heerspink, H. J. L. & DAPA-CKD Trial Comm Investigators, D. T. C. I., 2022, In: Nephrology Dialysis Transplantation. 37, 9, p. 1647–1656 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  18. Published

    Sodium–glucose cotransporter 2 inhibitors as adjunct therapy for type 1 diabetes and the benefit on cardiovascular and renal disease evaluated by Steno risk engines

    Stougaard, E. B., Rossing, Peter, Cherney, D., Vistisen, D. & Persson, F., 2022, In: Journal of Diabetes and its Complications. 36, 8, 108257.

    Research output: Contribution to journal › Journal article › Research › peer-review

  19. Published

    Sotagliflozin, a dual SGLT1 and SGLT2 inhibitor, reduces the risk of cardiovascular and renal disease as assessed by Steno Risk Engines in adults with type 1 diabetes

    Stougaard, E. B., Rossing, Peter, Vistisen, D., Banks, P., Girard, M., Davies, M. J. & Persson, F., 2022, In: Diabetologia. 65, SUPPL 1, p. S47 1 p.

    Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

  20. Published

    The Kidney Protective Effects of the Sodium–Glucose Cotransporter-2 Inhibitor, Dapagliflozin, Are Present in Patients With CKD Treated With Mineralocorticoid Receptor Antagonists

    Provenzano, M., Jongs, N., Vart, P., Stefánsson, B. V., Chertow, G. M., Langkilde, A. M., McMurray, J. J. V., Correa-Rotter, R., Rossing, Peter, Sjöström, C. D., Toto, R. D., Wheeler, D. C., Heerspink, H. J. L. & DAPA-CKD Trial Committees and Investigators, D. T. C. A. I., 2022, In: Kidney International Reports. 7, 3, p. 436-443

    Research output: Contribution to journal › Journal article › Research › peer-review

  21. Published

    The authors reply

    Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group, K. D. I. G. O. (. D. W. G., 2022, In: Kidney International. 101, 2, p. 420-421 2 p.

    Research output: Contribution to journal › Comment/debate › Research › peer-review

  22. Published

    The effect of liraglutide on cardiac autonomic function in type 2 diabetes: A prespecified secondary analysis from the LIRAFLAME randomized, double-blinded, placebo-controlled trial

    Sivalingam, S., Hein Zobel, E., Hansen, C. S., Ripa, Rasmus Sejersten, von Scholten, B. J., Rotbain Curovic, V., Kjær, Andreas, Jensen, Jacob Kildevang, Hansen, T. W. & Rossing, Peter, 2022, In: Diabetes, Obesity and Metabolism. 24, 8, p. 1638-1642

    Research output: Contribution to journal › Letter › Research › peer-review

  23. Published

    The novel inflammatory biomarker GlycA and triglyceride-rich lipoproteins are associated with the presence of subclinical myocardial dysfunction in subjects with type 1 diabetes mellitus

    Puig-Jové, C., Julve, J., Castelblanco, E., Julián, M. T., Amigó, N., Andersen, H. U., Ahluwalia, Tarun Veer Singh, Rossing, Peter, Mauricio, D., Jensen, M. T. & Alonso, N., 2022, In: Cardiovascular Diabetology. 21, 257.

    Research output: Contribution to journal › Journal article › Research › peer-review

  24. Published

    The potential of GLP-1 receptor agonists in type 2 diabetes and chronic kidney disease: from randomised trials to clinical practice

    von Scholten, B. J., Kreiner, F. F., Rasmussen, S., Rossing, Peter & Idorn, T., 2022, In: Therapeutic Advances in Endocrinology and Metabolism. 13, p. 1-14

    Research output: Contribution to journal › Review › Research › peer-review

  25. Published

    Urinary Proteomics Identifies Cathepsin D as a Biomarker of Rapid eGFR Decline in Type 1 Diabetes

    Limonte, C. P., Valo, E., Drel, V., Natarajan, L., Darshi, M., Forsblom, C., Henderson, C. M., Hoofnagle, A. N., Ju, W., Kretzler, M., Montemayor, D., Nair, V., Nelson, R. G., O’toole, J. F., Toto, R. D., Rosas, S. E., Ruzinski, J., Sandholm, N., Schmidt, I. M., Vaisar, T. & 12 others, Waikar, S. S., Zhang, J., Rossing, Peter, Ahluwalia, Tarun Veer Singh, Groop, P. H., Pennathur, S., Snell-Bergeon, J. K., Costacou, T., Orchard, T. J., Sharma, K., de Boer, I. H. & Kidney Precision Medicine Project, K. P. M. P., 2022, In: Diabetes Care. 45, 6, p. 1416-1427 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  26. 2021
  27. Published

    Ceramides and phospholipids are downregulated with liraglutide treatment: results from the LiraFlame randomized controlled trial

    Zobel, E. H., Wretlind, A., Ripa, Rasmus Sejersten, Rotbain Curovic, V., von Scholten, B. J., Suvitaival, T., Hansen, T. W., Kjær, Andreas, Legido-Quigley, C. & Rossing, Peter, Sep 2021, In: BMJ open diabetes research & care. 9, 1, p. 1-9 e002395.

    Research output: Contribution to journal › Journal article › Research › peer-review

  28. Published

    Sodium-glucose cotransporter 2 inhibitors as adjunct therapy for type 1 diabetes and the benefit on cardiovascular and renal disease evaluated by Steno risk engines

    Stougaard, E. B., Vistisen, D., Persson, F. & Rossing, Peter, Sep 2021, In: Diabetologia. 64, SUPPL 1, p. 319-319 1 p., 606.

    Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

  29. Published

    Response to Comment on Vistisen et al. A validated prediction model for endstage kidney disease in type 1 diabetes. Diabetes care 2021;44:901–907

    Vistisen, D., Andersen, G. S., Hulman, A., McGurnaghan, S. J., Colhoun, H. M., Henriksen, J. E., Thomsen, R. W., Persson, F., Rossing, Peter & Jørgensen, M. E., Jun 2021, In: Diabetes Care. 44, 6, p. e140-e141 2 p.

    Research output: Contribution to journal › Comment/debate › Research › peer-review

  30. Published

    A narrative review of new treatment options for chronic kidney disease in type 2 diabetes

    Persson, F., Borg, Rikke & Rossing, Peter, 1 Apr 2021, In: Annals of Translational Medicine. 9, 8, p. 716-716 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  31. Published

    A New Panel Estimated GFR, Including β2-Microglobulin and β-Trace Protein and Not Including Race, Developed in a Diverse Population

    CKD-EPI GFR Collaborators, C. G. C., 2021, In: American Journal of Kidney Diseases. 77, 5, p. 673-683

    Research output: Contribution to journal › Journal article › Research › peer-review

  32. Published

    A Validated Prediction Model for End-Stage Kidney Disease in Type 1 Diabetes

    Vistisen, D., Andersen, G. S., Hulman, A., McGurnaghan, S. J., Colhoun, H. M., Henriksen, J. E., Thomsen, R. W., Persson, F., Rossing, Peter & Jørgensen, M. E., 2021, In: Diabetes Care. 44, 3, 7 p., dc202586.

    Research output: Contribution to journal › Journal article › Research › peer-review

  33. Published

    A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy

    DAPA-CKD Trial Committees and Investigators, D. T. C. A. I., 2021, In: Kidney International. 100, 1, p. 215-224

    Research output: Contribution to journal › Journal article › Research › peer-review

  34. Published

    A primer on metabolic memory: Why existing diabesity treatments fail

    Copur, S., Rossing, Peter, Afsar, B., Sag, A. A., Siriopol, D., Kuwabara, M., Ortiz, A. & Kanbay, M., 2021, In: Clinical Kidney Journal. 14, 3, p. 756-767 12 p.

    Research output: Contribution to journal › Review › Research › peer-review

  35. Published

    Acute effects of dapagliflozin on renal oxygenation and perfusion in type 1 diabetes with albuminuria: A randomised, double-blind, placebo-controlled crossover trial

    Laursen, J. C., Søndergaard-Heinrich, N., de Melo, J. M. L., Haddock, B., Rasmussen, I. K. B., Safavimanesh, F., Hansen, C. S., Størling, Joachim, Larsson, Henrik Bo Wiberg, Groop, P., Frimodt-Møller, M., Andersen, U. B. & Rossing, Peter, 2021, In: EClinicalMedicine. 37, 10 p., 100895.

    Research output: Contribution to journal › Journal article › Research › peer-review

  36. Published

    Association of coding variants in hydroxysteroid 17-beta dehydrogenase 14 (HSD17B14) with reduced progression to end stage kidney disease in type 1 diabetes

    Mychaleckyj, J. C., Valo, E., Ichimura, T., Ahluwalia, T. S., Dina, C., Miller, R. G., Shabalin, I. G., Gyorgy, B., Cao, J. J., Onengut-Gumuscu, S., Satake, E., Smiles, A. M., Haukka, J. K., Tregouet, D. A., Costacou, T., O’Neil, K., Paterson, A. D., Forsblom, C., Keenan, H. A., Pezzolesi, M. G. & 16 others, Pragnell, M., Galecki, A., Rich, S. S., Sandholm, N., Klein, R., Klein, B. E., Susztak, K., Orchard, T. J., Korstanje, R., King, G. L., Hadjadj, S., Rossing, Peter, Bonventre, J. V., Groop, P. H., Warram, J. H. & Krolewski, A. S., 2021, In: Journal of the American Society of Nephrology. 32, 10, p. 2634-2651 18 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  37. Published

    Biomarkers for early detection of kidney disease: a call for pathophysiological relevance

    Siwy, J., Mischak, H., Beige, J., Rossing, Peter & Stegmayr, B., 2021, In: Kidney International. 99, 5, p. 1240-1241 2 p.

    Research output: Contribution to journal › Comment/debate › Research › peer-review

  38. Published

    Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes

    Pitt, B., Filippatos, G., Agarwal, R., Anker, S. D., Bakris, G. L., Rossing, Peter, Joseph, A., Kolkhof, P., Nowack, C., Schloemer, P., Ruilope, L. M. & FIGARO DKD Investigators, F. D. I., 2021, In: New England Journal of Medicine. 385, p. 2252-2263 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  39. Published

    Cardiovascular autonomic neuropathy and the impact on progression of diabetic kidney disease in type 1 diabetes

    Bjerre-Christensen, T., Winther, S. A., Tofte, N., Theilade, S., Ahluwalia, Tarun Veer Singh, Lajer, M., Hansen, T. W., Rossing, Peter & Hansen, C. S., 2021, In: B M J Open Diabetes Research & Care. 9, 1, 9 p., e002289.

    Research output: Contribution to journal › Journal article › Research › peer-review

  40. Published

    Changes in Albuminuria Predict Cardiovascular and Renal Outcomes in Type 2 Diabetes: A Post Hoc Analysis of the LEADER Trial

    Persson, F., Bain, S. C., Mosenzon, O., Heerspink, H. J. L., Mann, J. F. E., Pratley, R., Raz, I., Idorn, T., Rasmussen, S., von Scholten, B. J., Rossing, Peter & LEADER Trial Investigators, L. T. I., 2021, In: Diabetes Care. 44, 3, 7 p., dc201622.

    Research output: Contribution to journal › Journal article › Research › peer-review

  41. Published

    Chronic Kidney Disease in Diabetes: Guidelines from KDIGO

    Khunti, K., De Boer, I. H. & Rossing, Peter, 2021, In: American Family Physician. 103, 11, p. 698-700

    Research output: Contribution to journal › Comment/debate › Research › peer-review

  42. Published

    Circulating Free Fatty Acid and Phospholipid Signature Predicts Early Rapid Kidney Function Decline in Patients With Type 1 Diabetes

    Afshinnia, F., Rajendiran, T. M., He, C., Byun, J., Montemayor, D., Darshi, M., Tumova, J., Kim, J., Limonte, C. P., Miller, R. G., Costacou, T., Orchard, T. J., Ahluwalia, Tarun Veer Singh, Rossing, Peter, Snell-Bergeon, J. K., de Boer, I. H., Natarajan, L., Michailidis, G., Sharma, K. & Pennathur, S., 2021, In: Diabetes Care. 44, 9, p. 2098-2106 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  43. Published

    Comparison of Natriuretic Peptides as Risk Markers for All-Cause Mortality and Cardiovascular and Renal Complications in Individuals With Type 1 Diabetes

    Tofte, N., Theilade, S., Winther, S. A., Birkelund, S., Goetze, Jens P. , Hansen, T. W. & Rossing, Peter, 2021, In: Diabetes Care. 44, 2, p. 595-603

    Research output: Contribution to journal › Journal article › Research › peer-review

  44. Published

    Data Sharing Under the General Data Protection Regulation: Time to Harmonize Law and Research Ethics?

    Vlahou, A., Hallinan, D., Apweiler, R., Argiles, A., Beige, J., Benigni, A., Bischoff, R., Black, P. C., Boehm, F., Céraline, J., Chrousos, G. P., Delles, C., Evenepoel, P., Fridolin, I., Glorieux, G., van Gool, A. J., Heidegger, I., Ioannidis, J. P. A., Jankowski, J., Jankowski, V. & 19 others, Jeronimo, C., Kamat, A. M., Masereeuw, R., Mayer, G., Mischak, H., Ortiz, A., Remuzzi, G., Rossing, Peter, Schanstra, J. P., Schmitz-Dräger, B. J., Spasovski, G., Staessen, J. A., Stamatialis, D., Stenvinkel, P., Wanner, C., Williams, S. B., Zannad, F., Zoccali, C. & Vanholder, R., 2021, In: Hypertension. 77, 4, p. 1029-1035

    Research output: Contribution to journal › Review › Research › peer-review

  45. Published

    Diabetes Management in Chronic Kidney Disease: Synopsis of the 2020 KDIGO Clinical Practice Guideline

    Navaneethan, S. D., Zoungas, S., Caramori, M. L., Chan, J. C. N., Heerspink, H. J. L., Hurst, C., Liew, A., Michos, E. D., Olowu, W. A., Sadusky, T., Tandon, N., Tuttle, K. R., Wanner, C., Wilkens, K. G., Lytvyn, L., Craig, J. C., Tunnicliffe, D. J., Howell, M., Tonelli, M., Cheung, M. & 4 others, Earley, A., Rossing, Peter, de Boer, I. H. & Khunti, K., 2021, In: Annals of Internal Medicine. 174, 3, p. 385-398

    Research output: Contribution to journal › Journal article › Research › peer-review

  46. Published

    Distinct Molecular Signatures of Clinical Clusters in People With Type 2 Diabetes: An IMI-RHAPSODY Study

    Slieker, R. C., Donnelly, L. A., Fitipaldi, H., Bouland, G. A., Giordano, G. N., Åkerlund, M., Gerl, M. J., Ahlqvist, E., Ali, A., Dragan, I., Elders, P., Festa, A., Hansen, M. K., van der Heijden, A. A., Mansour Aly, D., Kim, M., Kuznetsov, D., Mehl, F., Klose, C., Simons, K. & 15 others, Pavo, I., Pullen, T. J., Suvitaival, T., Wretlind, A., Rossing, Peter, Lyssenko, V., Legido Quigley, C., Groop, L., Thorens, B., Franks, P. W., Ibberson, M., Rutter, G. A., Beulens, J. W. J., 't Hart, L. M. & Pearson, E. R., 2021, In: Diabetes. 70, 11, p. 2683-2693 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  47. Published

    Early response in albuminuria and long-term kidney protection during treatment with an endothelin receptor antagonist: A prespecified analysis from the SONAR trial

    Heerspink, H. J. L., Xie, D., Bakris, G., Correa-Rotter, R., Hou, F. F., Kitzman, D. W., Kohan, D., Makino, H., McMurray, J. J. V., Perkovic, V., Rossing, Peter, Parving, H. H. & de Zeeuw, D., 2021, In: Journal of the American Society of Nephrology. 32, 11, p. 2900-2911

    Research output: Contribution to journal › Journal article › Research › peer-review

  48. Published

    Effect of 26 Weeks of Liraglutide Treatment on Coronary Artery Inflammation in Type 2 Diabetes Quantified by [64Cu]Cu-DOTATATE PET/CT: Results from the LIRAFLAME Trial

    Jensen, Jacob Kildevang, Zobel, E. H., von Scholten, B. J., Rotbain Curovic, V., Hansen, T. W., Rossing, Peter, Kjær, Andreas & Ripa, Rasmus Sejersten, 2021, In: Frontiers in Endocrinology. 12, 10 p., 790405.

    Research output: Contribution to journal › Journal article › Research › peer-review

  49. Published

    Effect of Dapagliflozin on Clinical Outcomes in Patients With Chronic Kidney Disease, With and Without Cardiovascular Disease

    McMurray, J. J. V., Wheeler, D. C., Stefánsson, B. V., Jongs, N., Postmus, D., Correa-Rotter, R., Chertow, G. M., Greene, T., Held, C., Hou, F., Mann, J. F. E., Rossing, Peter, Sjöström, C. D., Toto, R. D., Langkilde, A. M., Heerspink, H. J. L. & DAPA-CKD Trial Committees and Investigators, D. T. C. A. I., 2021, In: Circulation. 143, 5, p. 438-448

    Research output: Contribution to journal › Journal article › Research › peer-review

  50. Published

    Effect of Liraglutide on Arterial Inflammation Assessed as [F-18]FDG Uptake in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial

    Ripa, Rasmus Sejersten, Zobel, E. H., von Scholten, B. J., Jensen, Jacob Kildevang, Binderup, Tina, Diaz, L. J., Curovic, V. R., Hansen, T. W., Rossing, Peter & Kjær, Andreas, 2021, In: Circulation: Cardiovascular Imaging. 14, 7, 13 p., 012174.

    Research output: Contribution to journal › Journal article › Research › peer-review

  51. Published

    Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial

    Heerspink, H. J. L., Jongs, N., Chertow, G. M., Langkilde, A. M., McMurray, J. J. V., Correa-Rotter, R., Rossing, Peter, Sjöström, C. D., Stefansson, B. V., Toto, R. D., Wheeler, D. C., Greene, T. & DAPA-CKD Trial Committees and Investigators, D. T. C. A. I., 2021, In: The Lancet Diabetes and Endocrinology. 9, 11, p. 743-754 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  52. Published

    Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial

    Jongs, N., Greene, T., Chertow, G. M., McMurray, J. J. V., Langkilde, A. M., Correa-Rotter, R., Rossing, Peter, Sjöström, C. D., Stefansson, B. V., Toto, R. D., Wheeler, D. C., Heerspink, H. J. L. & DAPA-CKD Trial Committees and Investigators, D. T. C. A. I., 2021, In: The Lancet Diabetes and Endocrinology. 9, 11, p. 755-766 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 5 6 7 8 ...11 Next

ID: 12937790